hotspot -WSS

hotspot

author：focus 2025-09-27 09:44:40 - browse：56281

WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Long Covid research funding gets a major boost from NIH

WSS

As a primary care physician, here's how I hope to partner with AI

ACIP vaccine advisory panel sees its vacancies filled

ASCO eve: Let’s set the table for this year's meeting

Abbott's new heart device gets FDA advisory panel nod

Liver decline slowed by off

Reports of telehealth's death have been greatly exaggerated

focus

hotspot

entertainment

Affirmative action in medical school literally saved lives

Eyeing GLP

Heart attack and stroke risk calculators need revising

Doctors on social media are being harassed and cyberbullied

Heart attack and stroke risk calculators need revising

Here’s what’s in the FDA plan to include pregnant women in clinical trials

United colonoscopy coverage change 'may cost lives,' doctors say

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Medicare details structure of new drug price negotiation program

Investigation reveals sickle cell patients pressured into sterilizations

focus

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Congress might make insulin pumps more accessible to the blind

Artificial intelligence use in health care faces greater scrutiny in 2024

Congress might make insulin pumps more accessible to the blind

Biogen joins immunology wave with $1.15 billion acquisition of HI

Latigo launches with $135 million for Vertex

hotspot

knowledge

knowledge

hotspot